Latest Commercial Strategy News

Orthocell’s new study confirms Remplir™ delivers superior nerve regeneration and faster muscle recovery compared to traditional sutures, bolstering its US market rollout plans.

EBR Systems has successfully completed a heavily oversubscribed Security Purchase Plan, raising a total of A$75.9 million alongside a prior institutional placement to fund its innovative wireless cardiac pacing technology through 2027.

EMVision Medical Devices has secured a $5 million non-dilutive government grant to accelerate global commercialisation of its innovative First Responder portable brain scanner, aimed at revolutionising pre-hospital stroke and brain injury care.

Control Bionics is on track for its strongest financial year yet, driven by robust US and Australian sales and promising global trials of its NeuroStrip® device.

FirstWave Cloud Technology has secured a strategic partnership with Amazon Web Services and Corent Technology to launch its IT compliance and network management software on the AWS Marketplace within weeks, aiming to expand its global reach and monetise its large user base.

Optiscan Imaging Ltd has launched InSpecta™, a cutting-edge microscopic imaging device tailored for veterinary medicine, marking its strategic entry into a booming $12 billion US market. The device promises to revolutionize diagnostics and treatment for companion animals with real-time, non-invasive imaging.

American West Metals is ramping up exploration and development at its West Desert Project in Utah, targeting critical metals like indium, molybdenum, and gallium amid supportive US government policies and tightening Chinese export controls.

Nanollose Limited has appointed Andrew Moullin as its new CEO and Managing Director, aiming to leverage his extensive commercial expertise to fast-track the company’s microbial cellulose technology towards market readiness.

RareX Limited has partnered with Gega Elements to develop Australia’s inaugural integrated gallium supply chain, aiming to reduce reliance on Chinese supply and boost national critical mineral resilience.

MTM Critical Metals has confirmed the scalability of its Flash Joule Heating reactor, paving the way for commercial operations at its Texas facility later this year. The modular design promises potential throughput beyond initial targets.

Core Lithium has terminated its legacy spodumene offtake agreement with Yahua through a $2 million cash settlement, unlocking strategic flexibility for its Finniss Lithium Operation restart plans.

Orthocell has secured regulatory approval to sell its nerve repair product Remplir™ in Hong Kong well ahead of schedule, expanding its footprint across key global markets. This milestone complements recent clearances in the US, Canada, and Asia, positioning the company for significant growth in a multi-billion-dollar market.